Stay updated on Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial

Sign up to get notified when there's something new on the Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial page

  1. Check
    yesterday
    Change Detected
    Summary
    Adds new user guidance sections (How to Read a Study Record, Common Questions, How to Join a Study) and updates recruitment status to 'No longer looking for participants'. Also updates the Interventions label formatting from 'Intervention / Treatment' to 'Intervention/Treatment' and adds revision: v3.6.0, replacing the previous v3.5.5.
    Difference
    0.4%
    Check dated 2026-06-12T23:52:04.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    Revision tag updated from v3.5.4 to v3.5.5 on the page, indicating a small maintenance or content update to the study record. This change does not necessarily alter the study details or user-facing information.
    Difference
    0.0%
    Check dated 2026-06-05T21:36:53.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    30 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.5.4, replacing the previous v3.5.3. This reflects a minor site version update for the study record and does not alter the study details or related information.
    Difference
    0.0%
    Check dated 2026-05-15T15:51:13.000Z thumbnail image
  6. Check
    51 days ago
    Change Detected
    Summary
    The page footer/site release label has been updated from revision v3.5.2 to v3.5.3, reflecting a website software update rather than any change to the study record itself.
    Difference
    0.0%
    Check dated 2026-04-24T05:54:51.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-17T02:40:08.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    A new page revision v3.5.0 was added and the previous revision v3.4.3 was removed.
    Difference
    0.0%
    Check dated 2026-03-19T04:52:01.000Z thumbnail image

Stay in the know with updates to Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Efprezimod Alfa as Immunomodulator in COVID-19 Clinical Trial page.